List of Ulesfia drug patents

Ulesfia is owned by Shionogi Inc.

Ulesfia contains Benzyl Alcohol.

Ulesfia has a total of 2 drug patents out of which 1 drug patent has expired.

Expired drug patents of Ulesfia are:

  • US6793931

Ulesfia was authorised for market use on 09 April, 2009.

Ulesfia is available in lotion;topical dosage forms.

Ulesfia can be used as topical treatment of lice infestations.

The generics of Ulesfia are possible to be released after 19 May, 2024.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6793931 SHIONOGI INC Ectoparasite asphyxiator compositions and methods for their applications
Jul, 2022

(6 months ago)

US7294342 SHIONOGI INC Ectoparasite asphyxiator compositions and methods for their application
May, 2024

(1 year, 3 months from now)

Drugs and Companies using BENZYL ALCOHOL ingredient

Market Authorisation Date: 09 April, 2009

Treatment: Topical treatment of lice infestations


How can I launch a generic of ULESFIA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in